NSCB Medical College looks to start plasma therapy trials

 

Considering the lack of potential treatment to fight COVID-19, the administration at Netaji Subhash Chandra Bose Medical College and Hospital (NSCBMCH) is making proposal to introduce or clinical trials of Convalescent Plasma Therapy for COVID-19 patients.

 

Though the process is in its initial stage, but NSCB Medical College and Hospital has started initiative to introduce convalescent plasma as an effective weapon to defeat corona. Meanwhile, the administration is engaged in preparing a proposal, which will be tabled before the Ethical Committee of the college, for approval before being dispatched to the Indian Council for Medical Research, New Delhi for final approval.

 

When contacted, Dean, NSCB Medical College and Hospital, Dr Pradeep Kasar told ‘The Hitavada’, “We have started working on proposal and preparing ourselves to fulfill initial formalities to initiate plasma therapy in Jabalpur. Hopefully everything will be on right track and we will able to provide further relief to patients through plasma therapy.”

 

“Plasma therapy includes transfusion of certain components from the blood of persons who have recovered from COVID-19 infection into the patients who are critically infected or at high risk. We hope that this therapy will definitely improve the clinical outcome in patients with moderate infection,” added Dean, Dr Kasar.

It may be mentioned that doctors across the world are seriously looking at plasma therapy as a potential option for treatment of COVID-19. In plasma therapy, the doctors use blood donated by recovered patients to introduce antibodies in the under-treatment patients.